Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Nesser

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Drug and Alcohol Abuse|December 10, 2014
Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker's perspectiveShellie L Keast, Nancy Nesser, Kevin Farmer
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
State Medicaid Programs Bring Managed Care Tenets to Fee for ServiceShellie L Keast, Grant Skrepnek, Nancy Nesser
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid ProgramShellie L Keast, Arthur Owora, Nancy Nesser, et al.
Journal of the American Pharmacists Association : Japha|December 12, 2018
The pharmacist's role in shaping the future of value-based payment models in state Medicaid programsTerry Cothran, Bethany Holderread, Melissa Abbott, et al.
Research in Social & Administrative Pharmacy : RSAP|May 19, 2015
Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from researchShellie L Keast, Kevin Farmer, Michael Smith, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid PopulationShellie L Keast, Laura M Tidmore, Deborah Shropshire, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid programShellie L Keast, David Thompson, Kevin Farmer, et al.
Journal of Evaluation in Clinical Practice|November 29, 2018
National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the USTimothy Pham, R Chris Rathbun, Shellie Keast, et al.
Journal of the American Pharmacists Association : Japha|July 17, 2020
Practical opportunities for pharmacists to optimize psychotropic medication use among foster youthTammy L Lambert, Laura M Tidmore, Madison Holbrook, et al.
Journal of Mental Health (Abingdon, England)|October 21, 2015
Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment optionsAmany K Hassan, Kevin C Farmer, Nancy C Brahm, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Drug and Alcohol Abuse|December 10, 2014
Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker's perspectiveShellie L Keast, Nancy Nesser, Kevin Farmer
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
State Medicaid Programs Bring Managed Care Tenets to Fee for ServiceShellie L Keast, Grant Skrepnek, Nancy Nesser
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid ProgramShellie L Keast, Arthur Owora, Nancy Nesser, et al.
Journal of the American Pharmacists Association : Japha|December 12, 2018
The pharmacist's role in shaping the future of value-based payment models in state Medicaid programsTerry Cothran, Bethany Holderread, Melissa Abbott, et al.
Research in Social & Administrative Pharmacy : RSAP|May 19, 2015
Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from researchShellie L Keast, Kevin Farmer, Michael Smith, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid PopulationShellie L Keast, Laura M Tidmore, Deborah Shropshire, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid programShellie L Keast, David Thompson, Kevin Farmer, et al.
Journal of Evaluation in Clinical Practice|November 29, 2018
National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the USTimothy Pham, R Chris Rathbun, Shellie Keast, et al.
Journal of the American Pharmacists Association : Japha|July 17, 2020
Practical opportunities for pharmacists to optimize psychotropic medication use among foster youthTammy L Lambert, Laura M Tidmore, Madison Holbrook, et al.
Journal of Mental Health (Abingdon, England)|October 21, 2015
Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment optionsAmany K Hassan, Kevin C Farmer, Nancy C Brahm, et al.
Pageof 2